Study of ONO-4578 and XELOX/FOLFOX Plus Bevacizumab in Colorectal Cancer
Clinical trial NCT06547385 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06547385
- Sponsor
- Ono Pharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-13
- Primary completion
- 2027-10-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.